THE PREMIER MOLECULAR DIAGNOSTICS
AMVEL BUSINESS PARK, BRGY. SAN DIONISIO
PARANAQUE CITY, PHILIPPINES
tp.moleculardiagnostics@gmail.com
(02) 7906-9153
SARS-CoV2 RT-PCR REPORT
NAME:
TOSHIHIRO, ARISAKA
AGE & GENDER:
47/MALE
BIRTHDATE:
SEPTEMBER 05, 1973
CIVIL STATUS:
MARRIED
ADDRESS:
17 POLILLO STREET ALABANG LAS PIÑAS CITY, METRO
MANILA
NATIONALITY:
JAPANESE
CONTACT NO:
0915 293 3361
SPECIMEN NO:
2021-26722
DATE AND TIME COLLECTED:
APRIL-28-2021 ; 12:00 PM
DATE AND TIME RECEIVED:
APRIL-28-2021 ; 3:13 PM
DATE AND TIME RELEASED:
APRIL-29-2021 ; 2:00 PM
SPECIMEN TYPE:
OROPHARYNGEAL AND NASOPHARYNGEAL SWAB
RESULT
INTERPRETATION
NEGATIVE
SARS-CoV2 NOT DETECTED
METHODOLOGY:
TEST INFORMATION:
LIMITATIONS:
Real-Time Polymerase Chain Reaction (RT-PCR) test is a laboratory technique used
to detect nucleic acid from the Severe Respiratory Syndrome Coronavirus 2 or SARSCoV2 in both lower and upper respiratory specimens from individuals who meet the
Coronavirus Disease 2019 (COVID-19) clinical and epidemiological criteria.
The SANSURE Novel Coronavirus Nucleic Acid Diagnostic PCR Kit test is performed
for detection of RdRP region and N gene of SARS-CoV2. This test adopts Nucleic
Acid PCR Fluorescence Probing system to detect these genes in RT-PCR assay.
Detection of RNA is dependent on the viral load or number of copies present in the
specimen. Pre-analytical variables such as specimen quality, sample integrity and
transport conditions may affect the results.
VALIDATED BY:
PERFORMED BY:
ALEJANDRA A. LEGASPI, RMT
LIC NO. 0097363
Medical Analyst
VERIFIED BY:
EDNA MAY L. GO, MD, FPSP
LIC NO. 0081290
Pathologist
GAYEHEART M. GOMEZ, RMT
LIC NO. 0093641
Chief Medical Technologist, Quality Assurance Officer
Biosafety Officer
VERIFIED BY:
JOCELYN MYRA R. CAJA, MD, FPSP
LIC NO. 0076484
Head Pathologist
THE PREMIER MEDICAL CENTER
COVID-19 MOLECULAR LABORATORY DEPARTMENT